Bagging/Receiving of orders/contracts

Date: 25.08.2026 The Manager The Manager, BSE Limited NSE Limited, P. J. Towers, Dalal Street Exchange Plaza, Bandra Kurla Complex, Mumbai-400001 Bandra (E), Mumbai- 400051. (BSE Scrip Code: 544742) (NSE Symbol: SAIPARENT) Dear Sir/Madam, Unit: Sai Parenterals Limited Subject: Disclosure under Reg. 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2018 Pursuant to Regulation 30 read with Schedule III, Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform the Exchanges that the Company’s subsidiary Noumed Pharmaceuticals Pty Limited has renewed its long-term OTC Medicines Supply Agreement with one of Australia's leading, multi-billion-dollar pharmacy chains with an expanded product portfolio, a long agreement tenure, and a higher agreement value. The renewed agreement is for a 3-year term with a projected value of AUD 30 Million at an exchange rate of Rs.68.52/- (Sixty-Eight Rupees and Fifty-Two Paise Only) aggregating to approximately Rs. 204 Crores. The requisite details in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 are provided below. Name of the entity awarding the Australia’s Leading Pharmacy Network order(s)/contract(s) (Australia) Significant terms and conditions of The Subsidiary has renewed its long-term order(s)/contract(s) awarded in brief OTC Medicines Supply Agreement with one of Australia's leading, multi-billion-dollar pharmacy chains with an expanded product portfolio, a long agreement tenure, and a higher agreement value Whether order(s) / contract(s) have been International Entity awarded by domestic/ international entity Nature of order(s) / contract(s) OTC Medicines Supply Agreement Whether domestic or international International Time period by which the Effective Date: 24th August, 2026 order(s)/contract(s) is to be executed Contract Term: Three (3) years from the Effective Date; may be revised or terminated with 6 months' notice prior to expiry or extended expiry. Broad consideration or size of the Orders worth AUD 30 million order(s)/contract(s) (approximately Rs.204 Crores) whether the promoter/ promoter group / No, the promoter/ promoter group / group group companies have any interest in the companies do not have any interest in the entity that awarded the order(s)/contract(s)? entity that awarded the order(s)/contract(s) If yes, nature of interest and details thereof whether the order(s)/contract(s) would fall No, the order(s)/contract(s) would not fall within related party transactions? If yes, within related party transactions. whether the same is done at “arm’s length” This is for the information and records of the Exchanges, please. Thanking you, Yours faithfully, For Sai Parenterals Limited Mr. Anil Kumar Karusala Managing Director (DIN- 01866646)